Correction to: Perspective and Costing in Cost‑Effectiveness Analysis, 1974-2018.

Journal

PharmacoEconomics

ISSN: 1179-2027

Titre abrégé: Pharmacoeconomics

Pays: New Zealand

ID NLM: 9212404

Informations de publication

Date de publication:
Dec 2020

Historique:

pubmed: 23 10 2020

medline: 23 10 2020

entrez: 22 10 2020

Statut: ppublish

Résumé

The article Perspective and Costing in Cost-Effectiveness Analysis.

Identifiants

DOI: 10.1007/s40273-020-00968-6 PMID: 33089479 PMC: PMC7661411

pubmed: 33089479

doi: 10.1007/s40273-020-00968-6

pii: 10.1007/s40273-020-00968-6

pmc: PMC7661411

doi:

Types de publication

Published Erratum

Langues

eng

Pagination

1377

Commentaires et corrections

Type : ErratumFor

Auteurs

David D Kim (DD)

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 063, Boston, MA, 02111, USA. dkim3@tuftsmedicalcenter.org.

Department of Medicine, Tufts University School of Medicine, Boston, MA, USA. dkim3@tuftsmedicalcenter.org.

ORCID: 0000-0002-3383-8972

Madison C Silver (MC)

Center for the Evaluation of Value and Risk in Health, Institute for Clinical Research and Health Policy Studies, Tufts Medical Center, 800 Washington St, Box 063, Boston, MA, 02111, USA.

Natalia Kunst (N)

Department of Health Management and Health Economics, University of Oslo, Oslo, Norway.

Cancer Outcomes, Public Policy and Effectiveness Research (COPPER) Center, Yale University School of Medicine, New Haven, CT, USA.

LINK Medical Research, Oslo, Norway.